MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about UK:AZN

Recent news which mentions UK:AZN

< Previous 1 2 3 Next >
Roche strikes $3.1 billion deal to buy obesity-drug maker Carmot Therapeutics billion in race to rival Novo Nordisk’s Ozempic
Tickers LLY PFE WMT
Tags UK:AZN WMT LLY
From MarketWatch
AstraZeneca hikes earnings forecast as surging cancer drug sales offset plunging revenue from COVID vaccines
Tickers AZN
Tags UK:AZN AZN
From MarketWatch
Here’s what Ozempic, ASML and India’s fintech industry all have in common — and how one ETF takes advantage of all three
Tickers ACWX ASML FERG HDB
Tags JP:6758 DK:NOVO/B SPY
From MarketWatch
Startup Cerebras stands out in the high-risk AI chip arena: ‘No one has built a chip this big’
Tickers AMD GSK NVDA
Tags UK:AZN GSK AMD
From MarketWatch
This fund shows that industry expertise can help you make a lot of money in the stock market
Tickers ABBV ABT AKRO ETNB
Tags DK:NOVO/B SPY XBI
From MarketWatch
JPMorgan says there may be many oil crises this decade as it lifts rating on energy stocks
Tickers ATVI BKR MPC TS
Tags FR:UBI ES:REP ATVI
From MarketWatch
As Ozempic/Wegovy frenzy continues, Morgan Stanley lifts forecasts for weight-loss drugs to $77 billion
Tickers ALT CTLT GPCR LLY
Tags CH:BANB DK:NOVO/B CTLT
From MarketWatch
AstraZeneca shares slump after Phase 3 lung cancer drug study
Tickers AZN
Tags JP:4568 AZN UK:AZN
From MarketWatch
AstraZeneca to decarbonize U.S. footprint by turning cow manure into renewable natural gas
Tags UK:AZN NG00
From MarketWatch
AstraZeneca says disappointed with FDA Lynparza vote outcome
Tickers AZN
Tags AZN UK:AZN
From MarketWatch
Why a nasal vaccine could reduce the risk of COVID infections and new variants
Tickers BNTX MRNA PFE
Tags BNTX PFE UK:AZN
From MarketWatch
AstraZeneca says cancer drug Enhertu showed positive results
Tickers AZN
Tags JP:4568 UK:AZN AZN
From MarketWatch
FTSE 100 hits fresh record above 8,000 on weak pound and renewed demand for energy stocks
Tickers BBEU SPX VGK
Tags UK:SHEL UK:HSBA UK:RIO
From MarketWatch
Omicron strains remain dominant globally, and the WHO is monitoring four closely
Tickers AZN
Tags AZN UK:AZN
From MarketWatch
AstraZeneca says Forxiga approved in EU for heart failure
Tickers AZN
Tags UK:AZN AZN
From MarketWatch
Drug companies plan to raise prices on vital medicines to fund R&D, but they already spend more on shareholder returns
Tickers AZN BMY PFE SNY
Tags AZN UK:AZN SNY
From MarketWatch
Will 2023 be the year that pharma M&A makes a comeback?
Tickers ALBO AMGN AMYT APLS
Tags SPX HZNP UK:AZN
From MarketWatch
European drugmakers including AstraZeneca pony up for U.S.-listed biopharmas
Tickers ALBO AMYT AZN CINC
Tags FR:IPN UK:AZN AZN
From MarketWatch
Powell won’t stop rate hikes until he ‘terrifies’ the wealthiest of investors, says this CIO
Tickers AAPL AMC APE AZN
Tags NIO ES00 YM00
From MarketWatch
AstraZeneca will buy U.S.-based CinCor for cardiorenal asset
Tickers AZN CINC
Tags CINC AZN UK:AZN
From MarketWatch
AstraZeneca’s Forxiga gets EU approval recommendation for symptomatic chronic heart failure
Tickers AZN
Tags AZN UK:AZN
From MarketWatch
AstraZeneca’s Imfinzi plus Imjudo recommended for approval in the EU
Tickers AZN
Tags AZN UK:AZN
From MarketWatch
Netflix, Workday, Costco, Caterpillar and more: These stocks are Cowen’s favorites for 2023
Tickers ABB ADI AZN BMRN
Tags AZN ISEE COST
From MarketWatch
AstraZeneca lifts guidance after forecast-beating profit and sales
Tickers AZN
Tags AZN UK:AZN
From MarketWatch
Hospitalizations on the rise in New York City as new COVID strains spread rapidly
Tickers AAPL AZN PFE
Tags TW:2317 UK:AZN AZN
From MarketWatch
AstraZeneca says advanced trial of breast-cancer drug Capivasertib meets primary endpoints
Tickers AZN
Tags UK:AZN AZN
From MarketWatch
There’s a good bet to be made in this ‘un-investable’ country, says UBS
Tickers AAPL AMC AMD APE
Tags GSK HSBC GME
From MarketWatch
Europe may give COVID vaccines full marketing authorization to avoid annual review, and WHO backs Gilead’s Veklury for severe disease
Tickers AZN GILD MRNA NVAX
Tags PFE NVAX GILD
From MarketWatch
AstraZeneca, Eli Lilly and Roche among pharmaceutical companies upgraded for high returns on R&D investments, analysts say
Tickers ABBV AZN BMY LLY
Tags LLY FR:SAN CH:ROG
From MarketWatch
Jill Biden tests negative for COVID after rare rebound infection, and U.S. cases are rising in 12 states
Tickers AZN PFE
Tags PFE UK:AZN AZN
From MarketWatch
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
TOP
Email a Story